UK markets closed

GC Biopharma Corp. (006280.KS)

KSE - KSE Delayed price. Currency in KRW
Add to watchlist
111,900.00+800.00 (+0.72%)
At close: 03:30PM KST
Currency in KRW
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts2265
Avg. Estimate-197.56861,969.334,393.2
Low estimate-8045678343,652
High estimate4098053,5005,221
Year ago EPS-1,967155-2,3331,969.33
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts5577
Avg. Estimate371.94M453.6M1.74B1.84B
Low estimate359M442.7M1.7B1.79B
High estimate390M470.8M1.78B1.89B
Year ago sales383.77MN/A1.63B1.74B
Sales growth (year/est)-3.10%N/A6.90%6.00%
Earnings history31/03/202330/06/202330/09/202331/12/2023
Est. EPS-76.141,343.962,425.93-433.5
Actual EPS-1,9671551,220-1,740
Difference-1,890.86-1,188.96-1,205.93-1,306.5
Surprise %-2,483.40%-88.50%-49.70%-301.40%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-197.56861,969.334,393.2
7 days ago-197.56861,969.334,393.2
30 days ago548.5884.52,375.294,314.6
60 days ago548.5884.52,0654,314.6
90 days ago565.59092,679.574,893.4
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/A2
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimates006280.KSIndustrySector(s)S&P 500
Current qtr.90.00%N/AN/AN/A
Next qtr.342.60%N/AN/AN/A
Current year184.40%N/AN/AN/A
Next year123.10%N/AN/AN/A
Next 5 years (per annum)-10.67%N/AN/AN/A
Past 5 years (per annum)-9.96%N/AN/AN/A